Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryu Watanabe

Showing results (91-100 of 158) with videos related to

Pageof 16
Sort By:
Modern Rheumatology|January 25, 2018
Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosusTomonori Ishii, Yoshiya Tanaka, Atsushi Kawakami, et al.
Scientific Reports|July 2, 2021
A susceptibility locus in the IL12B but not LILRA3 region is associated with vascular damage in Takayasu arteritisKeiichiro Kadoba, Ryu Watanabe, Takeshi Iwasaki, et al.
Cell Metabolism|April 5, 2023
Spleen fibroblastic reticular cell-derived acetylcholine promotes lipid metabolism to drive autoreactive B cell responsesQin Zeng, Shuyi Wang, Mengyuan Li, et al.
Modern Rheumatology Case Reports|October 22, 2020
JAK2 mutation-positive polycythaemia vera associated with IgA vasculitis and nephrotic syndrome: a case reportHinako Kondo, Ryu Watanabe, Soshi Okazaki, et al.
Arthritis Research & Therapy|January 3, 2024
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritisTakeshi Iwasaki, Ryu Watanabe, Hiromu Ito, et al.
Cell Reports. Medicine|April 19, 2023
Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritisShozo Ohtsuki, Chenyao Wang, Ryu Watanabe, et al.
Arthritis Research & Therapy|July 10, 2025
Roles of JAK-STAT signaling and granulocyte-macrophage colony-stimulating factor in the development of osteitis and bone microstructure changes in rheumatoid arthritisTsuneyasu Yoshida, Yoshiki Murotani, Koichi Murata, et al.
Rheumatology International|July 9, 2021
Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patientsTomoya Nakajima, Ryu Watanabe, Motomu Hashimoto, et al.
Rheumatology (Oxford, England)|January 27, 2021
Prevalence of anxiety and depression in patients with rheumatoid arthritis before and during the COVID-19 pandemicTakahiro Itaya, Mie Torii, Motomu Hashimoto, et al.
Internal Medicine (Tokyo, Japan)|February 1, 2026
Macrophage Activation Syndrome Associated with Adult-onset Still's Disease Successfully Treated with Plasma Exchange and Canakinumab: A Case ReportWataru Kiyohara, Yuya Fujita, Muneyuki Hatta, et al.
Pageof 16

Showing results (91-100 of 158) with videos related to

Sort By:
Pageof 16
Modern Rheumatology|January 25, 2018
Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosusTomonori Ishii, Yoshiya Tanaka, Atsushi Kawakami, et al.
Scientific Reports|July 2, 2021
A susceptibility locus in the IL12B but not LILRA3 region is associated with vascular damage in Takayasu arteritisKeiichiro Kadoba, Ryu Watanabe, Takeshi Iwasaki, et al.
Cell Metabolism|April 5, 2023
Spleen fibroblastic reticular cell-derived acetylcholine promotes lipid metabolism to drive autoreactive B cell responsesQin Zeng, Shuyi Wang, Mengyuan Li, et al.
Modern Rheumatology Case Reports|October 22, 2020
JAK2 mutation-positive polycythaemia vera associated with IgA vasculitis and nephrotic syndrome: a case reportHinako Kondo, Ryu Watanabe, Soshi Okazaki, et al.
Arthritis Research & Therapy|January 3, 2024
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritisTakeshi Iwasaki, Ryu Watanabe, Hiromu Ito, et al.
Cell Reports. Medicine|April 19, 2023
Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritisShozo Ohtsuki, Chenyao Wang, Ryu Watanabe, et al.
Arthritis Research & Therapy|July 10, 2025
Roles of JAK-STAT signaling and granulocyte-macrophage colony-stimulating factor in the development of osteitis and bone microstructure changes in rheumatoid arthritisTsuneyasu Yoshida, Yoshiki Murotani, Koichi Murata, et al.
Rheumatology International|July 9, 2021
Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patientsTomoya Nakajima, Ryu Watanabe, Motomu Hashimoto, et al.
Rheumatology (Oxford, England)|January 27, 2021
Prevalence of anxiety and depression in patients with rheumatoid arthritis before and during the COVID-19 pandemicTakahiro Itaya, Mie Torii, Motomu Hashimoto, et al.
Internal Medicine (Tokyo, Japan)|February 1, 2026
Macrophage Activation Syndrome Associated with Adult-onset Still's Disease Successfully Treated with Plasma Exchange and Canakinumab: A Case ReportWataru Kiyohara, Yuya Fujita, Muneyuki Hatta, et al.
Pageof 16